Lv2
160 积分 2022-03-18 加入
TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond
28天前
已完结
TNFR2 signalling in inflammatory diseases
28天前
已完结
RNAi-based drug design: considerations and future directions
1个月前
已完结
Mechanistic insights into RNA cleavage by human Argonaute2–siRNA complex
1个月前
已完结
Megalin and cubilin: multifunctional endocytic receptors
3个月前
已完结
CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
3个月前
已完结
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
3个月前
已完结
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
3个月前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
6个月前
已完结
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study
6个月前
已完结
皖公网安备34019202002308
